07/10/08
Partnership with Catalent and The Medical House
Partnership for commercialization of adrenaline autoinjector in Europe
10/09/08
Stallergenes inaugurates the biggest pharmaceutical allergen production unit in the world
Stallergenes S.A. officially inaugurates its new pharmaceutical production...
04/09/08
Launch of Stallergenes Portugal internet website
Stallergenes announces the launch of its Portuguese affiliate’s...
| We comply with the HONcode standard for trustworthy health information: verify here. |
Last update: 07/10/2008
Stallergenes is an European biopharmaceutical laboratory specialising in the treatment by desensitisation of allergy-related respiratory conditions.
The Group's activities focus on research into allergy, and the development, production and distribution of allergen extracts for the curative treatment of allergic rhinitis and asthma.
Visit the investors website
